Moderna Reaches Analyst Target Price
7/5 13:12
In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $46.85, changing hands for $48.82/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio...